NSE · MOL
Meghmani Organics Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹658 Cr with net profit ₹45 Cr — a 6.89% net margin, versus 11.01% the period before.
Shareholding
As of 2026-09-30
- Promoter48.95%
- Public50.21%
- FII0.84%
- DII0%
1,32,807 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.04× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Pesticides / Agrochemicals - Indian · ranked #11 of 30 by market cap · medians across 26 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| UPL Limited | ₹47,208 Cr | 24.55 | 1.34 | 5.42% | 3.59% |
| PI Industries Ltd. | ₹26,017 Cr | 32.81 | 2.27 | 7.66% | 13.84% |
| Sumitomo Chemical India Ltd. | ₹17,300 Cr | 31.39 | 4.68 | 15.12% | 17.35% |
| Sharda Cropchem Ltd. | ₹6,591 Cr | 10.24 | 2.02 | 19.8% | 11.75% |
| Dhanuka Agritech Ltd. | ₹4,047 Cr | 14.09 | 2.39 | 24.54% | 13.13% |
| Rallis India Ltd. | ₹3,680 Cr | 17.92 | 1.68 | 8.99% | 6.66% |
| NACL Industries Limited | ₹2,771 Cr | 328.58 | 3.94 | 1.2% | 0.58% |
| Bhagiradha Chemicals & Industries Ltd. | ₹2,438 Cr | 88.67 | 3.4 | 3.83% | 4.31% |
| Bharat Rasayan Ltd. | ₹1,750 Cr | 11.97 | 1.37 | 10.26% | 10.77% |
| Insecticides India Ltd. | ₹1,571 Cr | 12.85 | 1.19 | 9.26% | 5.8% |
| Meghmani Organics Limited(this company) | ₹1,412 Cr | 16.33 | 0.87 | 5.32% | 3.95% |
AI analysis
AI-generated · google/gemini-2.5-flashMeghmani Organics Limited (`MOL`) is an agro chemicals company with a market capitalization of Rs 1383 Cr. The company's PE ratio is 170 and its book value stands at Rs 60.74. Meghmani Organics Limited reported an EPS of 1.13 and a return on equity (ROE) of 186.04%. The return on capital employed (ROCE) is 6.75%, and the debt-to-equity ratio is 0.55.
Positives
- +The profit margin is significantly high at 132.16%.
- +Return on equity (ROE) is 186.04%, indicating high profitability relative to shareholders' equity.
- +Promoter share pledge is 0% as of June 30, 2026.
- +Revenue growth stands at 32.78%.
Negatives
- −The company's PE ratio is very high at 170.
- −The quarterly net profit has decreased to Rs 8.03 Cr in Mar 2026, from Rs 12.68 Cr in Jun 2025.
- −The FII holding has significantly decreased to 0.91% in June 2026 from 1.57% in December 2022.
- −The company reported a net loss of Rs -10.60 Cr for the annual period ending Mar 2025.
- −The latest quarterly figures show a negative net profit for Dec 2025 at Rs -3.53 Cr and for Dec 2024 at Rs -4.39 Cr.
Financial Performance
The company's revenue growth was 32.78%. In the annual period ending Mar 2025, revenue was Rs 2123.62 Cr, with a net loss of Rs -10.60 Cr. Quarterly revenue for Mar 2026 was Rs 474.34 Cr, marking a decrease from Rs 613.62 Cr in Jun 2025. Net profit for Mar 2026 was Rs 8.03 Cr, following a net loss of Rs -3.53 Cr in Dec 2025.
Profitability & Returns
Meghmani Organics Limited reported a profit margin of 132.16%. The return on equity (ROE) is 186.04% and the return on capital employed (ROCE) is 6.75%. The EPS for the latest period is 1.13. For the annual period ending Mar 2025, the company recorded a net loss of Rs -10.60 Cr.
Balance Sheet
The company maintains a debt-to-equity ratio of 0.55. The book value per share is Rs 60.74. No dividend yield is reported for the company.
Ownership & Pledges
There are no promoter shares pledged. The number of shareholders is 135,999.
Regulatory & Surveillance
No special surveillance measures have been reported for Meghmani Organics Limited. The company has not reported any pledged shares by its promoters, maintaining a promoter pledge of 0% as of June 30, 2026.
Data as of — price: 2026-11-14 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.